Home
Drugs
Atezolizumab
Clinical Trials

Clinical Trials Related to Atezolizumab

Related studies linked through entity extraction aliases.

A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in BRAFV600 Mutation-positive Melanoma With Central Nervous System Metastases

Status: COMPLETED
Phase: PHASE2

Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer

Status: UNKNOWN
Phase: PHASE2

This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated Cancers

Status: TERMINATED
Phase: PHASE1

Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC

Status: UNKNOWN
Phase: PHASE2

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab

Status: COMPLETED
Phase: PHASE2

Atezolizumab Trial in Endometrial Cancer - AtTEnd

Status: COMPLETED
Phase: PHASE3

Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer

Status: COMPLETED
Phase: PHASE3

Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Study to Evaluate CCS1477 in Advanced Tumours

Status: COMPLETED
Phase: PHASE1/PHASE2

Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer

Status: TERMINATED
Phase: PHASE1/PHASE2

A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE2

The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior Chemotherapy

Status: COMPLETED
Phase: N/A

Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the Cervix

Status: COMPLETED
Phase: PHASE3

A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC)

Status: TERMINATED
Phase: PHASE1/PHASE2

Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma

Status: COMPLETED
Phase: PHASE2

Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)

Status: RECRUITING
Phase: PHASE2

Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2